In this edition of our newsletter, we document a press release from Umea University suggesting that the presence of the Herpes Simplex virus increases the risk of developing Alzheimer’s Disease.
If this hypothesis is true that the Herpes Simplex virus may be a contributing factor to Alzheimer’s Disease then it would make sense that the usage of antiviral compounds could be of benefit in helping to prevent the development of Alzheimer’s Disease.
We have written some previous articles on Alzheimer’s Disease in this newsletter, including the following:
Alzheimer’s: Protocols and Compounds Proven to Work
Is Alzheimer’s a Prion Driven Process?
Alzheimer’s would appear to be a multi-factorial process and certainly the best cure is prevention, however recent published research (as indicated in the article above) would suggest that it is a condition for which progression can be halted and even reversed.
From the article linked above:
“Alzheimer’s disease appears to be the consequence of several convergent factors including oxidative stress, inflammation, mitochondrial dysfunction, and accumulation of toxic protein aggregates in and around neurons (Luan 2012; Teng 2012; Rosales-Corral 2012; Wang 2007; Fonte 2011; Ittner 2011). Emerging, intriguing research implicates chronic infection with several pathogenic organisms in the development and progression of Alzheimer’s disease as well (Miklossy 2011). Moreover, age-related changes such as declining hormone levels and vascular dysfunction are thought to contribute to some aspects of Alzheimer’s disease (Vest 2012; Barron 2012; Baloyannis 2012)”.
Here is a list of suggested causative factors:
Copyright © 2018 R. V. Lamberton & Associates, All rights reserved